Frontiers in Cardiovascular Medicine (Jul 2021)

The Innate Immune cGAS-STING-Pathway in Cardiovascular Diseases – A Mini Review

  • Lavinia Rech,
  • Peter P. Rainer,
  • Peter P. Rainer

DOI
https://doi.org/10.3389/fcvm.2021.715903
Journal volume & issue
Vol. 8

Abstract

Read online

Inflammation plays a central role in cardiovascular diseases (CVD). One pathway under investigation is the innate immune DNA sensor cyclic GMP-AMP synthase (cGAS) and its downstream receptor stimulator of interferon genes (STING). cGAS-STING upregulates type I interferons in response to pathogens. Recent studies show that also self-DNA may activate cGAS-STING, for instance, DNA released from nuclei or mitochondria during obesity or myocardial infarction. Here, we focus on emerging evidence describing the interaction of cGAS-STING with cardiovascular risk factors and disease. We also touch on translational therapeutic opportunities and potential further investigations.

Keywords